These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13512123)

  • 1. Pathogenesis of orinase-induced beta-cell degranulation.
    VOLK BW; LAZARUS SS
    Diabetes; 1958; 7(2):125-8. PubMed ID: 13512123
    [No Abstract]   [Full Text] [Related]  

  • 2. Some effects of tolbutamide on the pancreatic islet of growing rats.
    MOSCA L
    Q J Exp Physiol Cogn Med Sci; 1958 Jul; 43(3):265-9. PubMed ID: 13554758
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of HB 419 and tolbutamide on isolated islands of Langerhans in rats].
    Löffler G; Trautschold I; Schweitzer T; Lohmann E
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1469-72. PubMed ID: 4899090
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative studies on the effect of oral antidiabetics upon isolated rat islets of Langerhans].
    Tjioe TO; Puchinger H; Wacker A
    Hoppe Seylers Z Physiol Chem; 1970 Mar; 351(3):313-9. PubMed ID: 4911893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lesions of alpha-cells of the islands of Langerhans and hypoglycemic effect of indole-3-acetic acid and sulfanilylbutylcarbamide].
    KOREC R; HERKEL'OVA L
    Cesk Fysiol; 1958 Sep; 7(5):492-3. PubMed ID: 13629616
    [No Abstract]   [Full Text] [Related]  

  • 6. [QUANTITATIVE STUDY OF NEOGENESIS OF THE ISLANDS OF LANGERHANS OF THE PANCREAS INDUCED BY A HYPOGLYCEMIC SULFONAMIDE, TOLBUTAMIDE].
    LOUBATIERES A; FRUTEAUDELACLOS C; HOUAREAU MH; ALRIC R
    C R Seances Soc Biol Fil; 1963; 157():1652-4. PubMed ID: 14109095
    [No Abstract]   [Full Text] [Related]  

  • 7. [Histological study of the effect of the hypoglycemic sulphamides on the islands of Langerhans of the rat; study of the effect of BZ-55 treatment associated with cortisone].
    GEPTS W
    Ann Endocrinol (Paris); 1957; 18(2):204-17. PubMed ID: 13458919
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of the action of three hypoglycemic compounds on the blood sugar and the islet cells of the pancreas in the rat.
    LUNDBAEK K; NIELSEN K
    Acta Endocrinol (Copenh); 1958 Mar; 27(3):325-38. PubMed ID: 13507989
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the disposition of blood glucose; a comparison of insulin and orinase.
    ASHMORE J; CAHILL GF; EARLE AS; ZOTTU S
    Diabetes; 1958; 7(1):1-8. PubMed ID: 13490233
    [No Abstract]   [Full Text] [Related]  

  • 10. [Roentgenhistoradiographic research on the islet cells of the pancreas following stimulation by the oral antidiabetic D-860].
    MULLER D; SANDRITTER W
    Exp Cell Res; 1958 Oct; 15(2):441-3. PubMed ID: 13597910
    [No Abstract]   [Full Text] [Related]  

  • 11. Some metabolic actions of orinase.
    BRESSLER R; ENGEL FL
    Proc Soc Exp Biol Med; 1957; 95(4):738-41. PubMed ID: 13465789
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the effect of oral antidiabetic compounds on glucose tolerance, on islet cell structure, and on the in vitro metabolism of isolated muscle.
    LUNDBAEK K; NIELSEN K; RAFAELSEN OJ
    Ann N Y Acad Sci; 1959 Mar; 74(3):419-26. PubMed ID: 13637580
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors determining the liver glycogenating action of orinase.
    HENRY WL; KIM JH; HALL AS
    Am J Physiol; 1958 Mar; 192(3):514-6. PubMed ID: 13520946
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction in the activity of the pancreatic islets induced in normal rodents by prolonged treatment with derivatives of sulfonylurea.
    Sodoyez JC; Sodoyez-Goffaux F; Dunbar JC; Foa PP
    Diabetes; 1970 Sep; 19(9):603-9. PubMed ID: 4918835
    [No Abstract]   [Full Text] [Related]  

  • 16. [Light-optic morphological studies on the B-cells of the islets of langerhans after administration of HB 419].
    Bänder A; Pfaff W; Schesmer G
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1448-51. PubMed ID: 4899085
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of increasing concentrations of glucose on insulin secretion. Synergy between glucose and hypoglycemic sulfonamides].
    Loubatières A; Mariani MM; Chapal J
    C R Seances Soc Biol Fil; 1968; 162(8):1575-80. PubMed ID: 4238184
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nesocytotropic effect in vitro. (Pancreatic islet cell lesions in the isolated organ)].
    BECKER V; BRODEHL J; BURCK HC; SCHAEPER G
    Klin Wochenschr; 1962 Aug; 40():793-6. PubMed ID: 13866370
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of BZ-55 on the pancreatic islets.
    SCHOLER HF; GAARENSTROOM JH
    Acta Endocrinol (Copenh); 1958 Sep; 29(1):147-59. PubMed ID: 13582540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.